An Open Letter to Senator Sanders Challenging the Characterization of Meeting with HIV/AIDS Activists
Story: Cure for HIV Possible “Within Three Years”
April 2016 The Daily Telegraph article and examples of the media coverage that followed it: Cure for HIV possible within three years as scientists snip virus from cells– The Daily Telegraph, April 1, 2016. Update April 6, 2016: After receiving complaints, The Daily…
The Low Cost of Universal Access
Generic treatments for HIV, viral hepatitis, and cancer can be affordably—and profitably—mass-produced for broad, unobstructed availability By Tracy Swan TAG talks with Andrew Hill, senior visiting research fellow in the University of Liverpool’s Department of Pharmacology, about his group’s work…
PrEP Pricing Problems
A number of barriers to pre-exposure prophylaxis (PrEP) uptake, use, and adherence have been identified—cost shouldn’t be one of them By James Krellenstein and Jeremiah Johnson On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences’…
HIV Community Letter to Hillary for America
AIDS Advocates from Across the U.S. Call upon Presidential Candidates to Make Ending the Epidemic a Priority
Pre-CROI Community HIV Cure Research Workshop 2016
On Sunday February 21, 2016 in Boston, the AIDS Treatment Activists Coalition, AVAC, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research. The workshop has become an annual event that takes place immediately…
Treatment Action Group hails Governor Cuomo’s proposed legislation allowing minors to maintain confidentiality when obtaining HIV treatment or preventive therapy
Countering Threats to AIDS Research at NIH: What Happened and What You Can Do
February 2, 2016 In an alarming shakeup to the HIV/AIDS community, the U.S. Congress dropped annual budget language that allocated 10% of the National Institutes of Health (NIH) yearly funding towards HIV/AIDS research. The sudden reallocation of resources for…